CARLSBAD, Calif., Sept 13, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it is now shipping the Ion Proton™ System. The platform's speed, ease-of-use and affordability will democratize genome sequencing. For the first time, genome-scale sequencing is accessible to all scientists and medical researchers, enabling an unprecedented wave of innovation in life sciences and the advancement of clinical research.
"The Ion Proton System is an important milestone in our vision to drive innovation, economic growth and scientific progress by transforming the genome center into a simple desktop sequencer," said Gregory T. Lucier, Chairman and Chief Executive Officer of Life Technologies. "A key area where we will see these future advances is in clinical research, where physician-scientists dealing with previously intractable conditions like cancer will finally have the tools to confidently understand, identify and treat the disease. This is an inflection point in the history of research, and there is much more to come."
Previously, genome-scale sequencing has only been possible at large centers or core labs because it required specialized molecular biology skills, expensive sequencers, extensive IT infrastructure and large numbers of bioinformatics specialists. With the introduction of the Ion Proton™ System, Life Technologies now offers a solution to overcome all of these barriers, enabling scientists to sequence within budget, on schedule and on the bench top in their own labs.
Automated sample prep for all labs Life Technologies is introducing two new automated template preparation instruments: the Ion OneTouch™ 2 System and Ion Chef™ System. The Ion OneTouch™ 2 System is ideal for labs with a Proton and medium throughput requirements. The Ion Chef™ System is ideal for labs with any level of molecular biology expertise, or for labs with high-throughput requirements. It automates the upfront sequencing workflow, going from library to "loaded chips" with just minutes of hands-on time, and is scheduled to ship in the first half of next year.Semiconductor technology enables sequencing for all budgets, in all labsThe Ion Proton™ System is one-third the cost of light-based genome-scale sequencing systems, saving researchers hundreds of thousands of dollars. Additionally, at just $1,000 per run, scientists can afford to follow a one-off idea or invest in a major study. Using the Ion PI™ Chip, available today, the system can sequence exomes and transcriptomes in just two to four hours. Initially the system will deliver 60-80 million filtered reads and up to 10 Gb of output, with potential for higher performance. Read-lengths are 100 to 200 bp and the consensus accuracy is comparable to that of the Ion PGM™ sequencer. Life Technologies plans to ship more than 100 Ion Proton™ Systems to customers in September and continues to take additional orders and experience strong customer demand for the platform.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts